TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.

Mojun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.